Get the tools used by (smart)2 investors.

Positive EPS Revisions Ratio, Last 30 Days for Accolade Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ACCD: Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the heal...

6.99 USD
Price
USD
Fair Value
Upside
3.08 - 9.67
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Accolade Inc's Positive EPS Revisions Ratio, Last 30 Days:

Feb 2016Feb 2018Feb 2020Feb 2022Feb 20240.00%20.00%40.00%60.00%80.00%100.00%

Performance Summary
  • Accolade Inc's positive eps revisions ratio, last 30 days is 50.00%
  • Accolade Inc's positive eps revisions ratio, last 30 days for fiscal years ending February 2020 to 2024 averaged 68.22%.
  • Accolade Inc's operated at median positive eps revisions ratio, last 30 days of 80.00% from fiscal years ending February 2020 to 2024.
  • Looking back at the last 5 years, Accolade Inc's positive eps revisions ratio, last 30 days peaked in February 2021 at 83.33%.

How does Accolade's Positive EPS Revisions Ratio, Last 30 Days benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Accolade Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Positive EPS Revisions Ratio, Last 30 Days

Hide this widget
analyst_pos_eps_revisions_ratio_30d
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Positive EPS Revisions Ratio, Last 30 Days in the forecast category include:

View Full List

Search for metric or datapoint

Positive EPS Revisions Ratio, Last 30 Days

Represents a ratio of analysts that have revised EPS forecasts upwards divided by a count of all analysts covering the company in the last 30 days (ca...

Definition of Positive EPS Revisions Ratio, Last 30 Days

Hide this widget
Represents a ratio of analysts that have revised EPS forecasts upwards divided by a count of all analysts covering the company in the last 30 days (can be 0).

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.00%30.00%60.00%103.45%0100200300

The chart above depicts the distribution of positive eps revisions ratio, last 30 days for companies operating in the Healthcare sector in the Developed economic region. Over 850 companies were considered in this analysis, and 854 had meaningful values. The average positive eps revisions ratio, last 30 days of companies in the sector is 40.89% with a standard deviation of 40.79%.

Accolade Inc's Positive EPS Revisions Ratio, Last 30 Days of 50.00% ranks in the 65.0% percentile for the sector. The following table provides additional summary stats:

Positive EPS Revisions Ratio, Last 30 Days In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents854
Included Constituents854
Min0.00%
Max100.00%
Median33.33%
Mean40.89%
Standard Deviation40.79%

You can find companies with similar positive eps revisions ratio, last 30 days using this stock screener.

All rights reserved. Terms Of Use